GE Healthcare Inc.

GE Healthcare Inc., a division of General Electric Company headquartered in Arlington Heights, Illinois, manufactures and supplies medical imaging equipment, radiopharmaceuticals, contrast media, and associated repair and maintenance services to federal agencies as a large-business prime contractor across 87 customer agencies, with no small business set-aside designations across its recent prime footprint.

GE Healthcare operates almost exclusively as a prime contractor (100% of recent awards) across a broad portfolio of medical technologies. The company's concrete capability set centers on diagnostic imaging equipment (CT scanners, X-ray systems, ultrasound probes, MRI systems), radiopharmaceutical agents (DATSCAN for neuroimaging, Flyrcado for cardiac imaging, Iohexol contrast injection), medical laboratory and anesthesia equipment, and field service repair and maintenance for those systems. Representative recent work includes a $134.8 thousand Blanket Purchase Agreement call from Veterans Integrated Service Network 10 (April 2026) for radiopharmaceutical Ioflupane DATSCAN with completion through April 2029; a $114 thousand delivery order from VISN 10 (November 2025) for Flurpiridaz F-18 cardiac imaging radiopharmaceutical; a $36.8 thousand delivery order from VISN 8 (April 2026) for CT machine service repair at a Riviera Beach, Florida facility; a $64.9 thousand purchase order from Veterans Integrated Service Network 9 (June 2026) for a foot and ankle MRI coil; and a $386 thousand purchase order from the Indian Health Service (September 2025) for CT power injector consumables supporting the National Naval Medical Center.

Customer concentration is extreme and anchored by the Department of Veterans Affairs. The top five customers by potential value account for 78% of combined potential value, dominated by Veterans Integrated Service Network 12 alone, which carries $224.5 million across 17 awards — a single customer representing more than 72% of the total $311 million portfolio. By award count, the top five represent only 6% of the 6,162 total awards, indicating that GE Healthcare's dollar concentration diverges sharply from volume distribution; the VA system dominates dollars while the Navy Bureau of Medicine and Surgery, Defense Logistics Agency Troop Support Medical, and other service networks place many smaller orders. The Department of Veterans Affairs as a consolidated customer represents the overwhelming share of activity; other significant customers include the Navy, Army Medical Command, Indian Health Service, Defense Health Agency, and Bureau of Prisons facilities.

GE Healthcare's primary vehicle footprint is dominated by two VA-managed Federal Supply Schedule contracts. The Pharmaceuticals and Drugs FSS-61-IB contract, with a $104.36 million ceiling extended through September 2030, anchors 43 task orders carrying $1.7 million in combined potential value and serves as the parent vehicle for most radiopharmaceutical, contrast media, and consumable orders across the portfolio. A second Federal Supply Schedule vehicle (V797P5317X) carries 3,399 task orders valued at $13.5 million, and an Indefinite Delivery Contract (V797P5031E) carries 646 task orders valued at $6.8 million, indicating that GE Healthcare's federal footprint is built almost entirely on pre-positioned GSA and VA supply vehicles rather than competitive task order wins. These vehicles enable multiple federal agencies to place delivery orders on pre-negotiated terms without separate competitive solicitation.

Activity has moderated materially in the past two years. GE Healthcare recorded 27 awards in 2022, 31 in 2023, then declined to 10 in 2024 and recovered to 16 in 2025, with only 7 awards recorded year-to-date in 2026. Only five awards carrying $271 thousand in combined potential value face ultimate completion within the next twenty-four months, presenting minimal recompete exposure in that window. The portfolio shows 6,162 total awards since 1981, with $311 million in combined potential value and $52.6 million obligated (17% of potential).

The vendor's capability concentration by NAICS and PSC codes reflects a pharmaceutical-and-imaging-equipment manufacturer posture: Pharmaceutical Preparation Manufacturing accounts for 4,540 awards; Imaging Equipment and Supplies (Medical, Dental, Veterinary) represents 1,530 awards; and Medical and Surgical Instruments, Equipment, and Supplies comprise 1,420 awards. Within PSC codes, Drugs and Biologicals dominate at 2,311 awards, followed by Imaging Equipment (1,530 awards) and Medical and Surgical Instruments (1,420 awards). GE Healthcare competes in full-and-open, non-set-aside posture across all vehicles; the company's large-business classification precludes participation in 8(a), HUBZone, SDVOSB, and WOSB vehicles.